Caiyun Mu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Caiyun Mu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Anzhi Wang
China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China
1 shared publicationHuiwen Wang
China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China
1 shared publication- Jiaxing Hu
College of Acumox and Tuina (College of Rehabilitation Medicine), Anhui University of Chinese Medicine, Hefei 230012, China
1 shared publication Jiayi Yang
China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China
1 shared publicationJieying Zhang
China School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, PR China
1 shared publication- Junnan Jiang
College of Acumox and Tuina (College of Rehabilitation Medicine), Anhui University of Chinese Medicine, Hefei 230012, China
1 shared publication
Latest Publications
- Open Access
- 26 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9579
Epimedium: A Versatile Player in Bone Tissue Engineering
Epimedium is a traditional herb that has been investigated for its potential osteogenic and bone-regenerative effects, yet systematic analyses of its multi-component, multi-target mechanisms in bone metabolism and tissue engineering applications are limited. To address this knowledge gap, this narrative review systematically summarizes more than 20 bioactive constituents extracted from various parts of major medicinal Epimedium species. We elaborate on their pivotal roles in modulating osteogenic differentiation, suppressing osteoclastogenesis and bone resorption, regulating inflammatory responses, exerting antioxidant effects, promoting angiogenesis, demonstrating antitumor activity, exerting chondroprotective effects, and exhibiting antibacterial activity during bone defect repair. Furthermore, we highlight recent advancements and current trends in applying these bioactive constituents within the field of bone tissue engineering. Additionally, we compared the osteogenic and osteoprotective potentials of three metabolically related flavonoids (icariin, icaritin, and icariside II). Network pharmacology was utilized to elucidate their multi-target mechanisms in modulating bone metabolism, providing insights for future mechanistic studies. Despite the long-standing clinical use and extensive scientific investigation of Epimedium, this review identifies several challenges associated with its application in bone tissue engineering and offers constructive recommendations to overcome these limitations.
- 26 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9579
Open AccessEpimedium: A Versatile Player in Bone Tissue Engineering
Epimedium is a traditional herb that has been investigated for its potential osteogenic and bone-regenerative effects, yet systematic analyses of its multi-component, multi-target mechanisms in bone metabolism and tissue engineering applications are limited. To address this knowledge gap, this narrative review systematically summarizes more than 20 bioactive constituents extracted from various parts of major medicinal Epimedium species. We elaborate on their pivotal roles in modulating osteogenic differentiation, suppressing osteoclastogenesis and bone resorption, regulating inflammatory responses, exerting antioxidant effects, promoting angiogenesis, demonstrating antitumor activity, exerting chondroprotective effects, and exhibiting antibacterial activity during bone defect repair. Furthermore, we highlight recent advancements and current trends in applying these bioactive constituents within the field of bone tissue engineering. Additionally, we compared the osteogenic and osteoprotective potentials of three metabolically related flavonoids (icariin, icaritin, and icariside II). Network pharmacology was utilized to elucidate their multi-target mechanisms in modulating bone metabolism, providing insights for future mechanistic studies. Despite the long-standing clinical use and extensive scientific investigation of Epimedium, this review identifies several challenges associated with its application in bone tissue engineering and offers constructive recommendations to overcome these limitations.
- 3 February 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 183, 214759
A nanoengineered coating with dual antioxidant and immunomodulatory functions on titanium implants for osteoregeneration in osteoporosis
- 3 February 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 183, 214759
A nanoengineered coating with dual antioxidant and immunomodulatory functions on titanium implants for osteoregeneration in osteoporosis